Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106639954 | 10663995 | 4 | F | 2014 | 20160726 | 20141219 | 20160804 | EXP | CA-ABBVIE-14K-028-1321829-00 | ABBVIE | 62.15 | YR | F | Y | 53.57000 | KG | 20160804 | MD | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106639954 | 10663995 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 6059922 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | ||||||
| 106639954 | 10663995 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 6059922 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | /wk | ||||||
| 106639954 | 10663995 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 6059922 | 125057 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||||
| 106639954 | 10663995 | 4 | C | INDOCID | INDOMETHACIN | 1 | Oral | 0 | 50 | MG | |||||||||
| 106639954 | 10663995 | 5 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | 100 | UG | QD | ||||||||
| 106639954 | 10663995 | 6 | C | RABEPRAZOLE SODIUM. | RABEPRAZOLE SODIUM | 1 | 0 | 20 | MG | QD | |||||||||
| 106639954 | 10663995 | 7 | C | RABEPRAZOLE SODIUM. | RABEPRAZOLE SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106639954 | 10663995 | 1 | Crohn's disease |
| 106639954 | 10663995 | 4 | Arthritis |
| 106639954 | 10663995 | 5 | Hypothyroidism |
| 106639954 | 10663995 | 6 | Ulcer |
| 106639954 | 10663995 | 7 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106639954 | 10663995 | HO |
| 106639954 | 10663995 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106639954 | 10663995 | Asthenia | |
| 106639954 | 10663995 | Crohn's disease | |
| 106639954 | 10663995 | Diarrhoea | |
| 106639954 | 10663995 | Gastrointestinal infection | |
| 106639954 | 10663995 | Intestinal anastomosis complication | |
| 106639954 | 10663995 | Intestinal obstruction | |
| 106639954 | 10663995 | Intestinal perforation | |
| 106639954 | 10663995 | Nausea | |
| 106639954 | 10663995 | Procedural intestinal perforation | |
| 106639954 | 10663995 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106639954 | 10663995 | 1 | 20140819 | 20141031 | 0 | |
| 106639954 | 10663995 | 2 | 20141209 | 2016 | 0 | |
| 106639954 | 10663995 | 3 | 2016 | 0 | ||
| 106639954 | 10663995 | 4 | 2004 | 0 | ||
| 106639954 | 10663995 | 5 | 2008 | 0 | ||
| 106639954 | 10663995 | 6 | 2004 | 0 |